Effect of Albumin Infusion in Preterm Neonates with Hypoalbuminaemia
Myanmar Medical Journal · 2025
DOI: 10.64455/xmma0008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Myanmar Medical Journal, 2025. Verfasst von Myat Thida Seinn. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Hypoalbuminaemia is associated with poor outcomes in critically ill patients. Limited data are available regarding correction of hypoalbuminaemia in preterm neonates and their outcomes. To determine the effects of single 20% Human Albumin Solution (HAS) infusion in preterm neonates with hypoalbuminaemia. A hospital based prospective comparative study was undertaken from October 2021 to December 2022 among fifty-four preterm infants with hypoalbuminaemia (serum albumin ≤ 30 g/L) admitted to Neonatal Intensive Care Units (NICUs). No statistically significant difference regarding duration of respiratory support was identified between the two groups. However, infants in the intervention group achieved full enteral feeds significantly earlier (13.9 ± 6.9 hours vs 20.9 ± 12.3 hours; p = 0.036) and regained their birth weight significantly earlier (18.5 ± 7.2 hours vs 25.7 ± 9.3 hours: p = 0.007) compared to the control group. Single infusion of 20% HAS administered to preterm infants with hypo-albuminaemia provided
Zitieren
APA
Seinn, M. T. (2025). Effect of Albumin Infusion in Preterm Neonates with Hypoalbuminaemia. Myanmar Medical Journal. https://doi.org/10.64455/xmma0008
Vancouver
Seinn MT. Effect of Albumin Infusion in Preterm Neonates with Hypoalbuminaemia. Myanmar Medical Journal. 2025. doi:10.64455/xmma0008
BibTeX
@article{Seinn2025,
author = {Seinn, Myat Thida},
title = {Effect of Albumin Infusion in Preterm Neonates with Hypoalbuminaemia},
journal = {Myanmar Medical Journal},
year = {2025},
doi = {10.64455/xmma0008}
}
EUVIMED